Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
26 results
D1.136 - Allergen awareness of patients in allergology consultations at the pneumophthisiology department of the Ignace Deen University Hospital
D1.134 - Mapping the Patient’s Journey Prior to Allergen Immunotherapy
D1.135 - ”Bee Pollen” as a Potential Trigger for Anaphylaxis: A Case Study
D1.137 - Characterization of Pana g 1, a novel allergen from Korean ginseng, Panax ginseng triggering Pollen-Food Allergy Syndrome
D1.138 - IgE cross-reactivity between grass species in the presence of Japanese cedar pollen sensitization
D1.139 - Staphylococcus aureus (carriage and sensitization) - is it a significant factor in allergic rhinitis?
D1.144 - Global variations of IgE cross-reactivity in Cupressus allergy
D1.145 - A Clinical Decision Support System (CDSS) based on Machine Learning for the diagnosis of Seasonal Allergenic Rhinitis (SAR) and patient-tailored AIT prescription
D1.148 - Heterogeneity of sensitization profiles between Central and Southern European allergic patients
D1.435 - Eosinophilic diseases: from nasal polyposis, eosinophilic asthma to EGPA (Eosinophilic Vasculitis with PolyAngioitis), evaluation of possible biomarkers of disease evolution
D1.437 - Frequency of SNPs associated with pharmacogenetic phenotypes in Asthma in two Colombian populations
D1.439 - Is allergic conjunctivitis tip of the allergic iceberg ?
D1.440 - Single cell pipeline to improve immune cell annotation through comparison of multiple bioinformatic methods
D2.294 - Allergic contact dermatitis unit at Hospital Joan XXIII (Tarragona, Spain): descriptive analysis 2022 - 2023
D2.295 - Characterization of Treatment-Refractory Chronic Urticaria: A Large-Scale Retrospective Analysis of Clinical and Laboratory Parameters
D2.296 - Allergic contact dermatitis caused by a oxybutynin in a transdermal patch
D2.297 - SEP-631: A Novel Selective and Potent Oral MRGPRX2 Inhibitor for the Treatment of Chronic Spontaneous Urticaria
D2.299 - A novel synthetic molecule LN49 suppressed oxidative stress and inflammation in skin epithelial and fibroblast cells via activating Nrf-2 signaling pathway
D2.300 - Fixed Drug Eruption related to the use of NSAIDs
D2.302 - Non - immediate hypersensitivity to oxybutynin, first confirmed case with lymphocyte transformation test
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download